Dong Lu

机构：Fujian Medical University, Baylor College of Medicine, Shanghai University of Traditional Chinese Medicine, First Affiliated Hospital of Fujian Medical University, Shanghai Traditional Chinese Medicine Hospital, Shuguang Hospital · ORCID：0000-0002-9919-6378

发表论文 147 篇 · 总被引 4330 次 · h-index 31

代表论文

• A Mo-cation/O-anion doping strategy for creating vacancy defects and cation multivalency to enhance the hydrogen evolution of ZnS under visible light (2025 · Journal of Materials Chemistry A · 被引 41)
• Development of a RIPK1 degrader to enhance antitumor immunity (2024 · Nature Communications · 被引 31)
• Lysineless HiBiT and NanoLuc Tagging Systems as Alternative Tools for Monitoring Targeted Protein Degradation (2024 · ACS Medicinal Chemistry Letters · 被引 23)
• TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors (2025 · Cell Death and Disease · 被引 18)
• Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemia (2025 · Blood · 被引 12)
• One Tracer, Dual Platforms: Unlocking Versatility of Fluorescent Probes in TR-FRET and NanoBRET Target Engagement Assays (2025 · ACS Medicinal Chemistry Letters · 被引 6)